Biointelect

Biointelect offers consulting services for biopharmaceutical entities looking to commercialise new technologies to support an effective market entry strategy.

[Biointelect @BiointelectInfo]

💡 Ready to take your idea to the next level but wondering how to fund it? 💡

Register now for the Biointelect Venturer Program!
https://t.co/fqGL5DBaSr

The 2023 courses will be held across 5 states, with the first in Adelaide on Thursday 16th February.

[9News Australia @9NewsAUS]

NOVAVAX APPROVED: Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster in Australia.

Novavax, Inc today announced the TGA has granted provisional registration of the Nuvaxovid COVID-19 vaccine as a booster in individuals aged 18 and over. #9News

[Novavax @Novavax]

Novavax will be giving six different presentations showcasing our vaccine data at Australia's Communicable Diseases & Immunisation Conference, #CDIC2022. Learn more: https://t.co/gb61nALTe2

[The Lead Candidate Podcast @LeadCandidate]

This next episode we discuss with Jennifer Herz from #Biointelect how she and Karl Herz from #Biocelect established their #relationship with @novavax leading to Biocelect being their sponsor for the #covid19vaccine in Australia and New Zealand

[Biointelect @BiointelectInfo]

Congratulations to the Novavax and Biocelect team for this milestone https://t.co/ek6JAPY11X

[Biointelect @BiointelectInfo]

@normanswan @englishheadline @normanswan Novavax doses for Australia will be made from the supply network outside the US, so should be no impact;
Each regulator will be making their own assessment of the Novavax vaccine – including the MHRA, EMA and TGA, thanks for your coverage.

[Biointelect @BiointelectInfo]

@ARCSAustralia Thank-you @ARCSAustralia and @biomelbourne network for a great event. Congratulations to all the winners

[Biointelect @BiointelectInfo]

Come and meet the ⁦@BiointelectInfo⁩ team at booth 33 at the ⁦@ARCSAustralia⁩ 2021 conference #arcsaus #commercialisation

[ARCS Australia @ARCSAustralia]

Can’t wait to see you all today! #ARCSAus #ARCS2021

[Biointelect @BiointelectInfo]

Go @novavax and @nhs !

[Rebecca Clark @DrRebeccaClark]

Proof that you don’t need hundreds of people or large hospital trusts to recruit for large scale studies. This team of dedicated, wonderful NHS staff has now randomised 638 people to the @Novavax Phase 3 vaccine study and we’re not stopping there. #nextstop650

[Biointelect @BiointelectInfo]

Congratulations @novavax

[Novavax @Novavax]

This morning, we were pleased to announce the signing of a Heads of Terms agreement with the Australian Government for our #COVID #vaccine. Please read our announcement for details: https://t.co/ixUc9lDIf9 #vaccine $NVAX #australia

[Biointelect @BiointelectInfo]

Great panel discussion just now at @MTPConnect_AUS launch of @AAMRNet_ . @BiointelectInfo can support your business case, project management, grant writing as well as market access strategy for Antimicrobials

[Biointelect @BiointelectInfo]

Great news for @Novavax and for Australia to have this phase 1 trial starting in Melbourne abc supported by @TheNucleusNet and @360biolabs

[Novavax @Novavax]

$NVAX is very excited to have just announced initiation of the #phase1 portion of the Phase 1/2 clinical trial for #NVXCoV2373, our #COVID19 #vaccine . Read our news release to learn more to learn more at https://t.co/bDOaGeRtzt. #novavax2020

[Biointelect @BiointelectInfo]

@biomelb Thanks for the invite @biomelb very professionally organised and great group of workshop participants

[Biointelect @BiointelectInfo]

Congratulations to Biocelect for the launch of their first product !

[Biointelect @BiointelectInfo]

1st Shipment of Kodatef (tafenoquine succinate) for Malaria Prophylaxis arrives in Sydney https://t.co/0NDx3Su20b

[Biointelect @BiointelectInfo]

1st Shipment of Kodatef (tafenoquine succinate) for Malaria Prophylaxis arrives in Sydney https://t.co/0NDx3Su20b

[Biointelect @BiointelectInfo]

https://t.co/z7Rdbh1mCY https://t.co/WbhUccpp8M

[MTPConnect @MTPConnect_AUS]

In this week of #ICYMI - we feature activities from our CEO @DrDanGrant, our GM Stakeholder Engagement Dr Alfredo Martinez-Coll and our Director Major Projects @ElizabethStares https://t.co/EURwKbVGTw

[Biointelect @BiointelectInfo]

Encouraging #cancer patients and patient organisations to have their say about funding of new treatments - please complete our survey if you are interested https://t.co/ChlMNKTW30

[Biointelect @BiointelectInfo]

@BiointelectInfo at #AusBio18